Study found no link between migraine and Parkinson’s disease
On Aug. 21, 2024, Contrary to previous research, a new study of female participants finds no link between…
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
Biotechnology | Disease | FDA | Neurology | Therapeutics
Amneal Received U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease
On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
Biotechnology | Disease | FDA | Neurology | Non-Profit Research | Oncology
FDA Approved Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
the Lancet standing Commission Report: Dementia prevention, intervention, and care released
On Jul. 31, 2024, the Lancet Standing Commission released its 2024 Dementia prevention, intervention, and care report that…
Cannabinoid CBG reduced anxiety and stress in first human clinical trial
On Jul. 31, 2024, researchers at Washington State University (WSU) announced that the cannabigerol (CBG) effectively reduced anxiety…
Accuracy of diagnostic blood tests for Alzheimer’s disease varies
On Jul. 30, 2024, a head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by…
Researchers pinpoint brain cells that delay first bite of food
On Jul. 10, 2024, Scripps Research scientists announced they have identified a group of neurons in a small…
NIH researchers discovered a new face-detecting brain circuit
On Jul. 2, 2024, scientists at the National Institutes of Health (NIH) have uncovered a brain circuit in…
C2N’s Precivity™ Tests are Now Offered Through Mayo Clinic Laboratories
On Jun. 27, 2024, C2N Diagnostics (C2N), has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for…
Paralyzed mountain lion found in Colorado first case of “staggering disease” in North America
On Jul. 16, 2024, Colorado Parks and Wildlife officials announced the first finding of ‘rustrela virus’ in a…
How a few days in space can disrupt a person’s biology
On Jun. 12, 2024, scientists at Weill Cornell Medicine in New York City reported that just a few…
Biotechnology | Diagnostics | Infectious Disease | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics
CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
Biogen received European Commission approval for QALSODY® (tofersen), first therapy for rare, genetic form of ALS
On May 30, 2024, Biogen announced that the European Commission (EC) had granted marketing authorization under exceptional circumstances…
Findings from 23andMe research on Parkinson’s disease published in Brain
On May 29, 2024, 23andMe with support from The Michael J. Fox Foundation for Parkinson’s Research, announced it…
Scientists mapped networks regulating gene function in the human brain
On May 24, 2024, a consortium of researchers announced it had produced the largest and most advanced multidimensional…
Biotechnology | Disease | Life Science History | Medicine | Neurology | NIH
Scientists unraveled genetic basis for neurodegenerative disorders that affect vision
On May 15, 2024, a team of scientists led by National Institutes of Health (NIH) researchers announced it…
Black history month
Black History Month Celebrates the pioneering accomplishments of James McCune Smith, Rebecca Lee Crumpler, Alexa Canady and Patricia…
Biotechnology | COVID-19 | Diagnostics | Neurology | Vaccine
COVID vaccines not linked to seizures
On Apr. 30, 2024, a meta-analysis of six randomized controlled trials in JAMA Neurology found no increase in seizures in…
World’s first documented case of brain disease from fentanyl inhalation reported
On Apr. 29, 2024, Oregon Health Sciences University (OHSU) reported a patient with the first documented case of…
Biotechnology | Diagnostics | Disease | Neurology | Non-Profit Research | Ophthalmogy | Therapeutics
CIRM awarded $31 million to fund clinical-stage research for cancers and eye disease
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
Diagnostics | Disease | Medical Device | Nanotechnology | Neurology | Non-Profit Research | Therapeutics
Imaging technique shows new details of peptide structures
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
Study reveals no causal link between neurodevelopmental disorders and acetaminophen exposure before birth
On Apr. 11, 2024, a study of data from more than 2 million children in Sweden reported that…
NIH studies found severe symptoms of ‘Havana Syndrome,’ but no evidence of brain injury or abnormalities
On Mar. 18, 2024, using advanced imaging techniques and in-depth clinical assessments, a research team at the National…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
NIH researchers identified brain connections associated with ADHD in youth
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
On Feb. 24, 2024, C2N Diagnostics (C2N) announced the medical device registration from the United Kingdom’s Medicines and…
California’s Stem Cell Agency awarded $56 million for clinical research, $21.3 million for Shared Labs program
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
Gene study identifies DNA variants linked to dyslexia
On Jan. 25, 2024, a study led by the University of Edinburgh, is the largest genetic study of…
Biotechnology | COVID-19 | Diagnostics | Disease | Neurology | Therapeutics
Washington University’s Jeffrey T. Fort Neuroscience Research building dedicated
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…
‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in China
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…